Kost OA - Search Results

1

Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases.

Vaneev AN, Kost OA, Eremeev NL, Beznos OV, Alova AV, Gorelkin PV, Erofeev AS, Chesnokova NB, Kabanov AV, Klyachko NL. Vaneev AN, et al. Among authors: kost oa. Biomedicines. 2021 Apr 7;9(4):396. doi: 10.3390/biomedicines9040396. Biomedicines. 2021. PMID: 33917028 Free PMC article.

2

Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.

Kost OA, Beznos OV, Davydova NG, Manickam DS, Nikolskaya II, Guller AE, Binevski PV, Chesnokova NB, Shekhter AB, Klyachko NL, Kabanov AV. Kost OA, et al. Oxid Med Cell Longev. 2015;2015:5194239. doi: 10.1155/2016/5194239. Epub 2015 Dec 1. Oxid Med Cell Longev. 2015. PMID: 26697135 Free PMC article.

3

Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.

Vaneev A, Tikhomirova V, Chesnokova N, Popova E, Beznos O, Kost O, Klyachko N. Vaneev A, et al. Int J Mol Sci. 2021 Nov 16;22(22):12368. doi: 10.3390/ijms222212368. Int J Mol Sci. 2021. PMID: 34830247 Free PMC article. Review.

4

Chitosan-covered calcium phosphate particles as a drug vehicle for delivery to the eye.

Popova EV, Tikhomirova VE, Beznos OV, Chesnokova NB, Grigoriev YV, Klyachko NL, Kost OA. Popova EV, et al. Among authors: kost oa. Nanomedicine. 2022 Feb;40:102493. doi: 10.1016/j.nano.2021.102493. Epub 2021 Nov 12. Nanomedicine. 2022. PMID: 34775060

5

[Bradykinin and angiotensin-converting enzyme in serum of patients with diabetic retinopathy and the prognosis of diabetic macular edema development (pilot study)].

Neroev VV, Chesnokova NB, Kost OA, Okhotsimskaya TD, Pavlenko TA, Beznos OV, Binevsky PV, Lisovskaya OA. Neroev VV, et al. Among authors: kost oa. Probl Endokrinol (Mosk). 2021 Aug 19;67(4):13-19. doi: 10.14341/probl12762. Probl Endokrinol (Mosk). 2021. PMID: 34533010 Free PMC article. Russian.

6

[Oxidative stress in uveitis and its correction with superoxide dismutase antioxidative enzyme (experimental study)].

Chesnokova NB, Neroev VV, Beznos OV, Beĭshenova GA, Nikol'skaia II, Kost OA, Binevskiĭ PV, Shekhter AB. Chesnokova NB, et al. Among authors: kost oa. Vestn Oftalmol. 2014 Sep-Oct;130(5):30-4. Vestn Oftalmol. 2014. PMID: 25711059 Russian.

7

[Mental rationale for local use of angiotensin-converting enzyme in the treatment of inflammatory processes in the eye].

Chesnokova NB, Kost OA, Nikol'skaia II, Beznos OV, Binevskiĭ PV, Stoliarova EP, Pavlenko TA. Chesnokova NB, et al. Among authors: kost oa. Vestn Oftalmol. 2008 Mar-Apr;124(2):16-9. Vestn Oftalmol. 2008. PMID: 18488463 Russian.

8

Structural organization of membrane and soluble forms of somatic angiotensin-converting enzyme.

Grinshtein SV, Nikolskaya II, Klyachko NL, Levashov AV, Kost OA. Grinshtein SV, et al. Among authors: kost oa. Biochemistry (Mosc). 1999 May;64(5):571-80. Biochemistry (Mosc). 1999. PMID: 10381620

9

[Experimental rationale for local use of angiotensin-converting enzyme inhibitors for the treatment of ocular tissue ischemia on a model of postburn conjunctival ischemia].

Chesnokova NB, Kost OA, Nikol'skaia II, Beznos OV, Binevskiĭ PV, Makarov PV, Stoliarova EP, Pavlenko TA. Chesnokova NB, et al. Among authors: kost oa. Vestn Oftalmol. 2008 Jul-Aug;124(4):28-31. Vestn Oftalmol. 2008. PMID: 18756797 Russian.

10

[Production of timolol containing calcium-phosphate nanoparticles and evaluation of their effect on intraocular pressure in experiment].

Shimanovskaia EV, Beznos OV, Kliachko NL, Kost OA, Nikol'skaia II, Pavlenko TA, Chesnokova NB, Kabanov AV. Shimanovskaia EV, et al. Among authors: kost oa. Vestn Oftalmol. 2012 May-Jun;128(3):15-8. Vestn Oftalmol. 2012. PMID: 23120918 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page